N-Boc-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol
CAS228270-33-5
N-Boc-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol (CAS 228270-33-5, C12H21NO4) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 228270-33-5
- Formula
- C12H21NO4
- Mol. weight
- 243.29 g/mol
Chemical Specifications
Identifiers
| CAS number | 228270-33-5 |
|---|---|
| Product name | N-Boc-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol |
| Chinese name | 7-Boc-3-噁-7-氮杂双环[3.3.1]-9-壬醇 |
| Synonyms | N-Boc-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol |
| Molecular formula | C12H21NO4 |
| Molecular weight | 243.29 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of N-Boc-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol?
The CAS Registry Number of N-Boc-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol is 228270-33-5. N-Boc-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol is also known as N-Boc-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol.
What is the molecular formula and molecular weight of N-Boc-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol?
The molecular formula of N-Boc-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol is C12H21NO4, and its molecular weight is 243.29 g/mol.
How can I request a quotation for N-Boc-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol?
Send an inquiry for N-Boc-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol (CAS 228270-33-5) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for N-Boc-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.